Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms
- PMID: 35235159
- PMCID: PMC8890022
- DOI: 10.1007/s11033-022-07132-7
Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms
Abstract
The world is grappling with an unprecedented public health crisis COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2. Due to the high transmission/mortality rates and socioeconomic impacts of the COVID-19, its control is crucial. In the absence of specific treatment, vaccines represent the most efficient way to control and stop the pandemic. Many companies around the world are currently making efforts to develop the vaccine to combat COVID-19. This review outlines key strategies for generating SARS-CoV-2 vaccine candidates, along with the mechanism of action, advantages, and potential limitations of each vaccine. The use of nanomaterials and nanotechnology for COVID-19 vaccines development will also be discussed.
Keywords: COVID -19 vaccine platform; Nanoparticles-based vaccine; SARS-CoV-2; Vaccine candidate; Vaccine efficacy.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
The authors declare that there is no conflict of interest regarding the publication of this article.
Figures
References
-
- https://covid19.who.int/. Accessd 20 Dec 2021
-
- Control CfD Prevention Vaccine preventable deaths and the global immunization vision and strategy, 2006–2015. MMWR Morb Mortal Wkly Rep. 2006;55(18):511–515. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
